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ABSTRACT f-Amyloid protein (,B-A/4) is the major protein component of Alzheimer disease-related senile plaques and has
been postulated to be a significant contributing factor in the onset and/or progression of the disease. In the senile plaque, ,8-A/4
appears as bundles of amyloid fibrils. The biological activity of j-A/4 may be related to its state of aggregation. In this work,
self-assembly, fibril formation, and interfibrillary aggregation of 13(1-28), a synthetic peptide homologous with the amino-terminal
fragment of B-A/4, were investigated. The predominant form of 1(1-28) detected by size-exclusion chromatography and poly-
acrylamide gel electrophoresis was apparently a tetramer which does not bind Congo red. Aggregates containing cross-I3 sheet
structures which bind Congo red and thioflavin T were observed at concentrations of approximately 0.3 mg/ml or greater.
Concentrations of 0.5-1 mg/ml were necessary for aggregation into fibrils to be detectable by classical or quasielastic light
scattering. Both fibril elongation and fibril-fibril aggregation occur over the time scale investigated. The kinetics of aggregation
were much faster at physiological salt concentrations than at lower ionic strength. Ionic strength also appeared to influence the
morphology of the fibril aggregates. The data indicate that sample preparation method and sample history influence fibril size
and number density.
INTRODUCTION
,B-Amyloid protein (,B-A/4) has been identified as the major
protein component of neuritic plaques and cerebrovascular
amyloid deposits in patients with Alzheimer's disease
(Glenner and Wong, 1984; Wong et al., 1985; Masters et al.,
1985). ,B-A/4 is a 39- to 43-residue proteolytic product of a
normal membrane-associated precursor protein, with the
shorter, more soluble form present in cerebrovascular de-
posits and the longer forms present in senile plaques (Prelli
et al., 1988). The peptide contains an amino-terminal 28-
residue domain which is extracellular in the precursor pro-
tein, and a carboxyl-terminal 11-15 residue domain which is
part of the putative transmembrane domain of the precursor
(Kang et al., 1987; Selkoe et al., 1988). ,B-A/4 deposits in
senile plaques are organized as bundles of amyloid fibrils
surrounded by abnormal neurites (Merz et al., 1981). The
fibrils have an antiparallel (3-sheet conformation and are con-
ventionally detected by birefringence upon Congo red stain-
ing. Amorphous deposits of 3-A/4 unaccompanied by neu-
ritic damage have also been identified (Yamaguchi et al.,
1989, 1990; Rozemuller et al., 1989).
3-A/4 has been proposed to be a major causative factor in
the onset ofAlzheimer's disease (Joachim and Selkoe, 1992).
However, in vitro and in vivo assays of the biological activity
of synthetic homologs of 13-A/4 have given conflicting re-
sults (Whitson et al., 1989; Koh et al., 1990; Yankner et al.,
1990; Kowall et al., 1991, 1992; Emre et al., 1992; Podlisny
et al., 1992; Games et al., 1992; Rush et al., 1992; May et al.,
1992; Malouf et al., 1992; Koo et al., 1993). The aggregation
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state of the peptide has recently been recognized as a po-
tentially critical factor in determining the peptide's neuro-
toxic or neurotrophic activity (Cotman et al., 1992; Yankner,
1992). Neurotoxicity in in vivo studies has been correlated
with the presence of large, Congo red-staining fibrillar de-
posits of injected synthetic peptides (Waite et al., 1992). In
vitro studies showed that toxicity occurred only with "aged"
peptides which have aggregated (Pike et al., 1991a, 1991b).
Others have shown that "solubilizing" peptides enhances the
susceptibility of treated cells to injury from excitotoxins
(Mattson et al., 1992).
We report here investigations of amyloid fibril formation
from a synthetic peptide, 3(1-28), which is homologous to
the amino-terminal sequence of ,B-A/4. Previous researchers
have shown that ,B(1-28) adopts a random coil conformation
at physiological conditions (Barrow and Zagorski, 1991) and
spontaneously forms amyloid fibrils (Kirschner et al., 1987;
Castano et al., 1986; Gorevic et al., 1987). In some (Whitson
et al., 1989; Yankner et al., 1990) but not all (Pike et al.,
1991b, Malouf et al., 1992) cases, (3(1-28) has been shown
to exert neurotrophic and/or neurotoxic effects in vitro. In
work reported here, the kinetics of aggregation of ((1-28)
were investigated. Light scattering and electron microscopy
were used to characterize the rate and morphology of fibril
elongation and interfibrillary aggregation. Effects of salt and
peptide concentration were probed.
MATERIALS AND METHODS
Peptide Synthesis and Purification
A peptide homologous to the first 28 residues of ,B-A/4 (Kang et al., 1987)
was synthesized and purified at the University of Wisconsin Biotechnology
Center. The sequence is DAEFRHDSGYEVHHQKLVFFAEDVGSNK.
The peptide was stepwise synthesized on the Applied Biosystems (Foster
City, CA) automatic solid-phase peptide synthesizer. Stepwise coupling was
greater than 99% based on the quantitative ninhydrin test. Unpurified pep-
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tide was lyophilized and stored at -70°C. The crude peptide was purified
using reversed-phase high-pressure liquid chromatography (HPLC) on a
21.4 mm X 250 mm Dynamax-300 (Rainin, Woburn, MA) C18 column. To
purify, the peptide was dissolved in 0.1% trifluoroacetic acid (TFA), applied
to the column, and eluted in a gradient of 20-50% eluant B over 60 min
(eluant A, 0.1% TFA; eluant B, 80% acetonitrile and 0.086% TFA). Purity
was checked by analytical chromatography at a gradient of 20-50% eluant
B on a 4.6 mm X 250-mm Vydac (Hesperica, CA) C4 column. From the
chromatograms, purity was estimated to be 95-99%. The recovered peptide
was lyophilized and stored at -20°C in a dessicator. Mass spectroscopy
analysis indicated that the peptide had a molecular weight of 3263 + 1,
compared to the expected molecular weight of 3262.
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were obtained using a modified Cary Model
60 spectropolarimeter (On-line Instrument Systems, Bogart, GA). /3(1-28)
was prepared at a concentration of 0.2 mg/ml in 0.02 M phosphate buffer(K2HPO4/KH2PO4, pH 7.4, adjusted with NaOH). The peptide solution was
filtered through a 0.45-,um Millipore (Bedford, MA) filter to remove dust
and then placed into a vacuum system in order to discharge oxygen in the
solution. A 0.1-cm quartz cell was used for far-UV (190-240 nm) mea-
surements. The instrument was calibrated using D(+)-10-camphorsulfonic
acid. Spectra were measured approximately 3 h after sample preparation.
Ten scans each of duplicate samples were measured and averaged. Base line
scans were run in duplicate, averaged, and then subtracted from the sample
spectrum. The secondary structure was calculated from mean residue el-
lipticities using the secondary structural parameters reported by Chang
(Chang et al., 1978).
Congo red absorbance spectroscopy
Congo red dye (Sigma, St. Louis, MO) was dissolved in PBSA (0.01 M
K2HPO4/KH2PO4, 0.14 M NaCl, 0.02% NaN3, pH 7.4) to a final concen-
tration of 7,uM.,3(1-28) was dissolved directly into the Congo red solution
at 0.2-0.5 mg/ml and mixed gently at room temperature for 1 h. Spectro-
photometric measurements from 700 to 300 nm were collected for each of
the peptide-containing samples as well as for the free dye using a Hitachi
(San Jose, CA) U-2000 UV-Vis spectrophotometer and a quartz cell having
1-cm path length (Klunk et al., 1989a, 1989b). Difference spectra were
calculated by subtracting the free dye absorbance from the peptide-dye
solution absorbance.
Thioflavin T fluorescence spectroscopy
Stock solutions of Thioflavin T (ThT, Sigma, St. Louis, MO) were prepared
at 100,uM concentration. Lyophilized peptide was weighed and dissolved
in 0.01 M phosphate buffer or PBSA. Peptide samples (0.8 ml) were in-
cubated at room temperature for either 1 or 24 h, at which time 8-,ul ThT
stock solution was added (final ThT concentration, 1,uM). Fluorescence
intensity was measured immediately after briefly vortexing the sample.
Fluorescence measurements were obtained on a Model M-3 Alphascan
(Photon Technology International, South Brunswick, NJ) spectrofluorom-
eter. The sample chamber temperature was maintained at 250C. Preliminary
spectral measurements indicated that the peptide-dye mixture had an ex-
citation maximum at 450 nm and an emission maximum at 482 nm and that
the dye alone had essentially no fluorescence signal at these wavelengths,
in agreement with reported literature values (Naiki et al., 1989; LeVine,
1993). These maxima were not a function of ionic strength. Therefore, all
subsequent measurements were taken at an excitation wavelength of 450 nm
and an emission wavelength of 482 nm. For each sample, ten measurements
were taken and averaged; no increase in fluorescence during the measure-
ment period was detected. Baseline fluorescence was measured for buffer
containing the same quantity of ThT and subtracted.
HPLC
Size-exclusion HPLC experiments were conducted using the Waters (Mil-
lipore, Milford, MA) Model 625 LC system and the Waters Protein-Pak 125
column. PBSA was used as the mobile phase at a flow rate of 1.0 ml/min.
Lyophilized ,B(1-28) was weighed and dissolved in either PBSA or 0.01 M
phosphate buffer. Final concentrations were 0.2, 0.5, or 1.0 mg/ml; solution
pH was 7.4. 10-,ul samples were injected for each measurement and peaks
were detected by absorbance at 280 nm. The column was calibrated with
bovine serum albumin (67 kDa), ovalbumin (43 kDa), myoglobin (17 kDa),
ribonuclease A (14 kDa), insulin (4.7 kDa), and guanosine (283 Da).
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE)
SDS-PAGE experiments were performed under nonreducing conditions us-
ing the Pharmacia (Uppsala, Sweden) pHastGel System and pHastGel high
density homogeneous gels. Lyophilized peptide was weighed and dissolved
in 0.01 M phosphate buffer, then diluted further with 0.01 M phosphate
buffer containing NaCl, to a final peptide concentration of 1 or 0.5 mg/ml
and a final NaCl concentration of 0.14 M. Solutions were mixed with SDS
to give a final SDS concentration of 2.5% and were boiled for 5 min. Low
molecular mass calibration standards (16.9, 14.4, 10.7, 8.1,6.2, and 2.5 kDa,
from Pharmacia) were run alongside the sample.
The gel was stained using a silver staining technique per manufacturer's
instructions with minor modifications. Briefly, gels were fixed in 25% glu-
taraldehyde for 10 min, washed twice with water for 5 min, then stained in
a 0.5% silver nitrate solution for 45 min. After two washes with water, the
gels were developed in a 2.5% sodium carbonate buffer containing 0.015%
formaldehyde for approximately 12 min. Gels were soaked in a bath of 10%
aqueous acetic acid containing 10% glycerol for 30 min to preserve.
Light scattering
Buffers were filtered through a 0.22-,um filter and degassed prior to use.
Solutions were passed through a 0.45-jim Millipore filter to remove dust.
The concentration was re-examined by absorbance, and pH of the solution
was measured. The peptide solution was then transferred to a precleaned,
dust-free cuvette. The cuvette was placed in a sample holder, which con-
tained decahydronaphthalene (Aldrich Chemical Co., Milwaukee, WI) as a
refractive index matching fluid. The sample was maintained at 25 ± 0.1°C
using a temperature-controlled circulating water bath. Experiments were
performed using the Malvern (Spring Lane, United Kingdom) 4700c particle
analyzer with a 128-channel autocorrelator and a Lexel (Fremont, CA)
Model 95-2 argon-ion laser equipped with an etalon and operated at a power
of 75-200 mW and at a wavelength of 488 nm. In order to reduce stray light,
the equipment was enclosed in a black box.
Classical light scattering (CLS) experiments were performed essentially
as described previously (Tomski and Murphy, 1992). Briefly, the scattered
light intensity of the sample was collected for 20 s at 17 different angles
between 20° and 1400. Each measurement was repeated ten times, and then
averaged. The scattered light intensity of the buffer was then measured at
the same conditions and subtracted from the sample intensity. The results
were normalized with respect to intensity data from spectrophotometric
grade toluene (Aldrich) to obtain the Rayleigh ratio of the sample R,(q).For
dilute polydisperse solutions,
Rj(q) = EKjcjMjPj(q)[1 - 2BiciMiPi(q)] (1)
where the subscript i is a counter for each macromolecular species,
K = 4-rr2n2(dn/dc)2/NAA4, n is the refractive index of the solvent, dn/dc is
the refractive index increment, NA is Avogadro's number, Ao is the laser
wavelength in vacuo, c is concentration in g/ml, M is molecular weight, B
is the second virial coefficient, and P(q) is the particle structure factor which
accounts for intramolecular interference (Geiduschek and Holtzer, 1958).
For our system, K is assumed to be independent of state of aggregation.
At low angles (low q, where q= (4,Tm/Ao)sin(0/2) is the scattering vector)
and low concentration, Eq. 1 then simplifies to
Ks( 1 (2)Kc ~
~~1+ q2(R2)), 2
Rs(q) (M w,app 3 _
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where (M)w,app is the apparent weight-averaged molecular weight and
(R2 is the light-scattering-averaged squared radius of gyration. For rods,
(R2)1'2 corresponds to the radius of gyration of a rod of molecular weight
slightly greater than the z-average molecular weight and can be related to
the rod length as
(L)z= 12(R2)'2. (3)
A plot of Kc/R0(q) vs. q2 yields an intercept corresponding to the inverse of
(M)w,app and a slope from which (R2)1'2 can be calculated.
If the particles in solution are rigid rods which are heterogeneous in
diameter, then at low concentrations and large scattering angles (qL >> 1)
Eq. 1 simplifies to (Geiduschek and Holtzer, 1958)
Kc 2 (M/L2)W q
R,(q) w2 (MIL). ir(MIL)w (4)
A plot of KcIR0(q) vs. q yields a straight line. The inverse of the intercept
is proportional to an average molecular weight which for rods of homo-
geneous diameter reduces to the number-average molecular weight (M)n and
which we will refer to as (M),app. The slope is proportional to a weight-
average linear molecular density, which can be converted to a weight-
averaged rod diameter (d)0. using the estimated hydrated specific volume Vh
of 13(1-28) of 1.17 mlVg (Kuntz and Kauzmann, 1974; Cohn and Edsall,
1943) and the equation:
/M\ lr(d)2%NA
\L/W 4 Vh (5)
For determination of dn/dc, solutions of peptide were made up at known
concentrations and the refractive index of the solution was measured using
a Milton-Roy (Rochester, NY) Abbe-3L refractometer. The refractive index
increment was determined to be 0.24 ± 0.03 mlIg. Refractometer calibration
was checked using aqueous solutions of NaCl (Huglin, 1972).
For quasielastic light scattering (QLS) experiments, the scattered light
intensity at five angles (300, 450, 700, 900, and 1200) was collected and
converted to the normalized first-order electric field autocorrelation function
g(l)(T). Data were collected 20 times for 30-s duration each time and then
averaged. Data were analyzed using the method of cumulants (Koppel,
1972) where
lnI g(1)(T) =-(r)T + 2 2T2 _ 1 13T3 + . . .
length, respectively, andD = (2D1 + D3)/3. This equation incorporates the
effects of rotation and anisotropic translation on the diffusive motion de-
tected in QLS experiments. The factors fi and f2 are complex functions of
qL and were calculated from the numerical values given by Maeda and
Fujime (1984). The following limits apply
(F)
-2-=D (qL<<1)
q
(F) 1 L2
=D-
-A(D-Dj)+-OE (qL»>>1).3 1 12 (10)
The Broersma equations (Russo et al., 1984) were used to calculate the
translational diffusion coefficient D and the rotational diffusion coefficient
0 as a function of rod length and diameter. Specifically
D= kBT [8_ 1 ( 1+Y3)3irnqL [ 2'l Y )
- 3kT( - E)
/2L(8 = In d (11)
Y= 0.19 - 4.2(86 - 0.39)2
-3 1.27 - 7.4(8-1 - 0.34)2
E= 1.45 - 7.5(8-6 - 0.27)2.
The long-rod limit D3 = 2D1 was used to calculate these diffusivities from
the Broersma relations.
Electron microscopy
A drop of the peptide solution was placed on a Pioloform-coated 300-mesh
electron microscope copper grid. After blotting, a drop of 1% ammonium
molybdate was placed on the grid while it was held with fine forceps. The
grid was blotted on filter paper and allowed to dry before observing the
specimen in a JEOL (Peabody, MA) 100 CX Electron Microscope at 60 kV.
(6)
(F) is the initial decay rate and T is the decay time. The apparent translational
diffusion coefficient (D)z,app was calculated from
(D) -- 2 (7)
The notation indicates that the diffusion coefficient is z-averaged and is thus
weighted toward larger particles. This is an apparent diffusion coefficient
because the influence of particle shape factor, internal motions of the par-
ticle, or particle-particle interactions are not included. (D)z,app was converted
to an apparent hydrodynamic radius (Rh)z,app using the Stokes-Einstein
equation:
kBT
6*rqPP6X(D)zapp (8)
where kB is the Boltzmann constant and X is the solvent viscosity. Alter-
natively, data were fit to a diffusion coefficient distribution using the pro-
gram CONTIN (Provencher, 1982). Note that the inverse of the hydrody-
namic radius is z-averaged, and then inverted, to obtain (Rh)z,app.
Theoretical calculations of (F)1q2 vs. q2 for rods of various lengths and
diameters were carried out as follows. Maeda and Fujime (1984) derived the
following expression for a dilute solution of monodisperse rigid rods
(F) L2 (i
q2= D + (2efl + (D3- D, ) (f2-3 )(9)q 1 2 \3
where D1 and D3 are the diffusivities perpendicular and parallel to the rod
RESULTS
Secondary structure
The circular dichroism spectra of 13(1-28) is shown in Fig. 1.
Analysis of the spectra indicates that the peptide exists as
100% unordered conformation at these conditions.
Oligomerization
Peptide solutions were analyzed by size exclusion HPLC
repeatedly over a period of 7-10 days. A representative chro-
matogram is shown in Fig. 2. Analysis of the chromatograms
indicated the presence of one major peak, with an elution
time corresponding to a molecular weight of approximately
13,000 (tetramer), and a smaller peak with an elution time
corresponding to a molecular weight of a monomer. Chro-
matograms were not significantly different at any of the three
concentrations tested (0.2, 0.5, and 1.0 mg/ml), were not
affected by the presence or absence of NaCl in the injected
sample, and did not change substantially over the test period
(30 min to 7-10 days after sample preparation). The percent
monomer (based on the peak area for monomer relative to the
Shen et al. 2385
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FIGURE 1 Circular dichroism spectra for 0.2 mg/ml ,3(1-28) in 0.02 M
phosphate buffer, pH 7.4. The sample was analyzed 3 h after sample prepa-
ration.
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FIGURE 2 Representative size-exclusion HPLC chromatogram of
13(1-28). The mobile phase is PBSA.
total peak area) was relatively constant at -5 ± 2% inde-
pendent of concentration, salt content, or time after sample
preparation. Total peak area did not change significantly with
time after sample preparation.
The presence of peptide oligomers was further investi-
gated by SDS-PAGE. Representative results are shown in
Fig. 3. Two bands were detected: one corresponding to a
molecular mass of 4 kDa and a broader band corresponding
to a molecular mass of 11-13 kDa. A small band was also
detected which was excluded from the gel. Peptide solutions
were incubated from 1 h to 13 days prior to analysis. The
presence and distribution of bands did not change noticeably
with concentration or with aging of the sample.
In order to determine if the apparent tetramer bound Congo
red, either Congo red dye alone or a Congo red-peptide mix-
ture was injected into the column, with peak detection set at
485 nm. There was only a single peak in both cases at iden-
tical residence times, corresponding to the elution time of the
free dye, indicating that the dye did not co-elute with the
tetramer.
FIGURE 3 Representative SDS-PAGE gel. Lane 1, molecular weight
standards; lane 2, 1 mg/ml ,3(1-28); lane 3, 0.5 mg/ml ,3(1-28). The so-
lutions shown here were aged 19 days prior to application to the gel.
Shorter aging times did not materially alter the appearance of the gels.
Molecular masses of the protein markers (in kilodaltons) are shown to the
left of lane 1.
Cross-,B-pleated sheet structure
Congo red absorbance spectroscopy and ThT fluorescence
spectroscopy were used to probe for the presence of cross-
3-pleated sheet structure, a defining characteristic of amy-
loid fibrils. Difference spectra, shown in Fig. 4, indicated that
the degree of Congo red binding increased significantly as
the concentration increased from 0.2 to 0.5 mg/ml. Consis-
tent with the Congo red results, ThT fluorescence intensity
increased dramatically from 0.2 to 0.5 mg/ml (Fig. 5). There
was no significant difference between samples prepared at
low and physiological ionic strength.
In these experiments, Congo red absorbance spectra were
taken after incubating the peptide with the dye for 1 h,
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FIGURE 4 Absorbance difference spectra for 7 ,uM Congo red in the
presence of varying concentrations of 13(1-28) in PBSA. Samples were
incubated for 1 h at room temperature prior to analysis. Dotted line, 0.2
mg/ml; dash-dot line, 0.3 mg/ml; dash line, 0.4 mg/ml; solid line, 0.5 mg/ml.
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FIGURE 5 Fluorescence intensity of 1 ,uM ThT as a function of 13(1-28)
concentration. Solid circles show data taken in 0.01 M phosphate buffer (pH
7.4), and solid triangles show data taken in PBSA. Excitation was at 450
nm and emission at 482 nm. Peptide solutions were incubated for 24 h prior
to addition of ThT. Similar results were obtained for solutions incubated for
1 h prior to ThT addition.
whereas ThT fluorescence intensity measurements were
taken by incubating the peptide in the absence of the dye for
1 or 24 h, then adding the dye and rapidly taking the mea-
surement. No difference in the concentration threshold was
observed for these two different methods.
Fibril formation kinetics
Several (3(1-28) samples were subjected to light scattering
and electron microscopy analysis. Sample A was prepared
by dissolving 1 mg of lyophilized peptide in 1 ml of 0.01
M phosphate buffer (final pH 7.3). Total intensity mea-
surements were taken over time and analyzed using Eqs. 2
and 4. Representative data taken at 168 h after sample
preparation are shown in Fig. 6. Plots of Kc/R,(q) vs. q2
curved downward (Fig. 6 A), whereas plots of Kc/R5(q) vs.
q were linear (Fig. 6 B). Both of these results are consis-
tent with a rodlike particle structure. (M)w,app was calcu-
lated from the limiting slope as q2 approaches zero, per
Eq. 2. Results are shown in Fig. 7 and Table 1. (M)w,app
was 600 ± 90 kDa (corresponding to a weight-average of
185 monomers) after 8 h and increased by a factor of four
over the next 120 h. At this point there was a sharp in-
crease in the rate of growth. After 240 h, the solution was
diluted in half, to a peptide concentration of 0.5 mg/ml,
and data collection was continued for 6 more days. A sig-
nificant decrease in size occurred upon dilution, as shown
in Table 1 and Fig. 7.
(M)n,app was calculated from the plot ofKc/Rs(q) vs. q per
Eq. 4. Results are shown in Table 1. (M)n,app was 140 ± 10
kDa after 8 h, corresponding to 43 monomers per aggregate
on a number-averaged basis. (M)n,app increased with time,
concomitant with the increase in (M)W,app, although the rate
of increase was not nearly as rapid.
(R2) '/2 and (M/L), were determined from the slopes of the
data, plotted per Eqs. 2 and 4, respectively. Results are shown
1.5
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FIGURE 6 KcIR,(q) versus scattering vector for 1 mg/ml 13(1-28) in
0.01 M phosphate buffer (sample A). Data were collected 168 h after
sample preparation. Straight line shows linear fit to data using (A) Eq. 2
or (B) Eq. 4.
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FIGURE 7 (M)W,app versus time for 1 mg/ml 1(1-28) in 0.01 M phosphate
buffer (sample A). Sample was diluted in half 240 h after preparation.
in Table 1. (L), (Eq. 3) varied from approximately 900-1400
nm and (d), (Eq. 5) increased from 1.4 to 8.6 nm over this
time period. (R2)1/2 fluctuated considerably but did not
change significantly during the first 240 h. An increase in
(M/L), occurred with time (Table 1). Both (R 2)1/2 and (MIL),
decreased upon dilution.
I II
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TABLE I Analysis of classical light scattering data: sample A
(M/L). (M)w
109 g/mol-cm 103 g/mol
ND ND
ND ND
7.9 ± 0.8 602 ± 87
16.1 ± 0.8 1070 ± 3
16.1 ± 0.8 2890 ± 710
29.4 ± 3.2 NRt
31.6 ± 0.8 2420 ± 387
85.2 ± 0.8 7810 ± 2000
108.9 ± 0.8 10000 ± 5000
126.3 ± 1.6 22700 ± 6710
297.9 ± 1.6 40000 ± 8100
Sample was diluted to 0.5 mg/ml
264.3 ± 0.8 16200 ± 1370
203.0 ± 0.8 8260 ± 552
121.8 ± 0.8 2480 ± 114
(Rh)z
10-7 cm
ND
ND
267 ± 24
265 ± 2
447 ± 60
NR
210 ± 30
350 ± 50
360 ± 110
430 ± 70
360 ± 40
10-7 cm
42
60
107
136
190
203
225
327
416
588
659
280 ± 10
190 ± 10
128 ± 7
406
344
ND
* ND, not determined.
* NR, not reported.
QLS measurements were taken for the same sample over
the same time period. Data taken at 900 were analyzed for
apparent diffusion coefficients, and this was converted to an
apparent hydrodynamic radius. Results are shown in Fig. 8.
(Rh)z,app increased rapidly, then stabilized at approximately
250 nm from about 50-150 h, then increased rapidly again.
After 240 h, data collection was stopped because of the ap-
pearance of a damped oscillatory autocorrelation function.
Upon dilution to 0.5 mg/ml, measurements could again be
taken, and (Rh)z app decreased to about 300 nm.
QLS data were further analyzed as a function of angle.
Representative plots of (F)/q2 vs. q2are shown in Fig. 9. The
data are compared to theoretical calculations (Eqs. 9-11) for
rods of 5-nm hydrodynamic diameter and lengths of 500-
5000 nm. The data suggest that at early times (-1 h), the
fibrils have already reached lengths of approximately 500 nm
or more. With increasing time, the apparent length of the
FIGURE 8 (Rh)z,app versus time for 1 mg/ml ,B(1-28) in 0.01 M phosphate
buffer (sample A). Sample was diluted in half 240 h after preparation. Solid
circles show results from 900 QLS data using cumulants analysis; open
triangles show results based on CONTIN analysis. Error bars are approxi-
mately the size of the symbols. Fitting of data at longer times was attempted
with CONTIN; however, nonrandom residuals were obtained.
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FIGURE 9 (D)/q2 vs. q2 for 1 mg/ml (3(1-28) in 0.01 M phosphate buffer
(sampleA) 1 h (solid circles), 4 h (solid triangles), 8 h (solid squares), and
24 h (solid diamonds) after sample preparation. Lines represent calculations
based on Eqs. 9 and 11: d = 5 nm, L = 500 nm (solid line); d = 5 nm,
L = 1000 nm (dotted line); d = 5 nm, L = 2000 nm (dot-dash line); d =
5 nm, L = 5000 nm (dash line).
fibrils increased rapidly. Diffusivities measured at 24 h are
consistent with fibril lengths reaching 2000-5000 nm.
Electron micrographs of sample A were taken approxi-
mately 21 and 45 h after initial preparation. Additionally, the
sample which was studied extensively by CLS and QLS was
examined three months after preparation. At 21 h, only a few
rodlike fibrils were evident (Fig. 10 A). The fibrils showed
a definite twist, and had diameters of roughly 10 nm and
lengths of roughly 500-1000 nm. The fibril dimensions seen
on micrographs are similar to those reported by others (Cas-
tano et al., 1986; Kirschner et al., 1987; Fraser et al., 1991)
and are consistent with naturally occurring amyloid fibril
dimensions. After 45 h (Fig. 10 B), the number density of
fibrils had increased substantially. Rod diameter and fibril
morphology were similar; lengths were difficult to determine
precisely but were greater than 2000 nm in some cases. After
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A
E
FIGURE 10 Electron micrographs. (A) 1 mg/ml ,B(1-28) in 0.01 M phosphate buffer (sample A), 21 h after sample preparation, 90,000 X magnification.
(B) Same as A, except 45 h after sample preparation, 72,500 X magnification. (C) Diluted sample A, 3 months after sample preparation, 47,500 X
magnification. (D) 1 mg/ml ,B(1-28) in PBSA (sample D), 3 h after sample preparation, 72,500 X magnification. (E) Same as D, except taken 7 weeks
after sample preparation, 47,500 X magnification. (F) 1 mg/ml (3(1-28) at pH 4.4, 35,000 X magnification.
3 months, an extended entanglement of fibrils of similar di-
ameter but indeterminant lengths had formed (Fig. 10 C).
An attempt was made to measure the aggregation process
on a sample prepared in the same 0.01 M phosphate buffer
at 0.5 mg/ml initial concentration, but after 7 days no mea-
surable scattering signal was detected.
Sample B was prepared by dissolving 1 mg of lyophilized
f(1-28) in 0.5 ml of 0.01 M phosphate buffer, vortexing
briefly, then diluting in 0.5 ml of phosphate buffered saline
to produce a final NaCl concentration of 0.14 M and a final
pH of 7.3. QLS data were obtained for this sample and ana-
lyzed. Over the first 24 h, (Rh)z,app and (F)/q2 were quite
similar to that for sampleA (data not shown). However, after
24 h the sample containing NaCl increased sharply in size
and the autocorrelation function became oscillatory.
Samples C and D were prepared by dissolving 0.5 and 1.0
mg of lyophilized peptide, respectively, into PBSA. Final pH
was 7.5 for sample C and 7.3 for sample D. The aggregation
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rate was too rapid to collect CLS measurements. (Rh)z,app as
a function of time was determined by analysis of QLS data
taken at 90° (Fig. 11). There was a rapid increase in the
particle size, with the rate approximately tripling with a dou-
bling in the concentration. The experiments were stopped
due to the onset of an oscillatory autocorrelation function
after 8 h for 1 mg/ml and after 24 h for 0.5 mg/ml. Attempts
were made to collect data at 0.2 mg/ml in the same buffer;
however even after 9 days incubation there was no detectable
signal.
Multiangle QLS data for samples C and D were analyzed
and compared to theoretical calculations (Fig. 12). For both
samples C and D, diffusivities measured after 1 h were con-
sistent with fibril lengths of approximately 1000 nm. At 2 h
for sample D and 4 h for sample C, apparent fibril lengths
reached 5000 nm or more. Diffusivities dropped rapidly with
time, reaching extremely low values (-10-9 cm2/s) after
8-12 h. These low diffusivities are consistent with extremely
long fibrils, approaching apparent lengths of 50,000 nm.
Sample D was analyzed 3 h after preparation by electron
microscopy. Fibril morphology and diameter were similar to
those prepared at low ionic strength. At this early time, fibril
density was generally low, and lengths ranged from 600 to
3000 nm or more (Fig. 10 D). The same sample was in-
spected seven weeks later. A substantial amount of side-by-
side alignment of fibrils into large bundles had occurred by
this time (Fig. 10 E).
Effect of sample preparation method
The above experiments were all conducted by dissolving
lyophilized peptide directly into buffer. We conducted sev-
eral experiments in which samples were prepared by dilution
from a stock solution at 10 mg/ml peptide concentration pre-
pared in 0.1% TFA. ThT fluorescence intensity was meas-
ured for samples prepared from 0.1% TFA stock solutions
and diluted into PBSA. These samples showed a significant
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FIGURE 11 (Rh)z,app versus time for (3(1-28) in PBS
taken at 900 scattering angle and analyzed by the method
circles, 1 mg/ml (sample D); solid triangles, 0.5 mg/ni
circles, 1 mg/ml in PBSA (final concentration), prepared
of 10 mg/ml in 0.1% TFA.
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FIGURE 12 (A) (F)1q2 vs. q2 for 0.5 mg/ml (3(1-28) in PBSA (sample
C) 1 h (solid circles), 4 h (solid triangles), 8 h (solid squares), and 12 h
(solid diamonds) after sample preparation. (B) (1')/q2 vs. q2 for 1 mg/ml
(3(1-28) in PBSA (sample D) 1 h (solid circles), 2 h (solid triangles), 4 h
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increase in ThT fluorescence comparable to that shown in
Fig. 5, indicating the presence of cross-08-pleated sheet struc-
ture (data not shown). A sample was prepared by diluting the
A* 0.1% TFA stock solution into PBSA with a final peptide
concentration of 1 mg/ml and a fmal pH of 6.8. QLS mea-
surements taken on this sample indicated that the rate of
increase in size was similar to that for an equivalent sample
(sample D) prepared directly from lyophilized peptide (Fig.
11). However, the intensity of scattered light was consider-
ably diminished relative to that for sample D, indicating a
lower fibril concentration. Electron microscopy analysis
confirmed that there were far fewer fibrils present when the
peptide was prepared by dissolution first in TFA, although
20 25 the fibril morphology was similar (data not shown). Inter-
estingly, samples prepared by dissolving the stock solution
first in phosphate buffer containing no saline, then adding
iA. QLS data were saline to a final concentration of 0.14 M NaCl, showed no
of cumulants. Solid
(sample C); open detectable aggregation.
from stock solution We attempted to obtain light scattering results on a sample
prepared at 0.5 mg/ml and low pH (pH 4.6). The sample
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rapidly became turbid and a damped oscillatory autocorre-
lation function was observed. After filtration through a
0.45-,uM filter, no signal was obtained from the supernatant.
Electron micrographs of a sample prepared in this manner
showed more heterogeneity in rod diameter, more hetero-
geneity in length, and less lateral aggregation than the sample
prepared at neutral pH (Fig. 10 F).
DISCUSSION
,3-A/4 has been proposed to be a causative agent in the onset
or development of neuronal disorders in Alzheimer's dis-
ease. Toxicity studies with synthetic versions of 13-A/4 have
led to inconclusive results. Given recent data that the ag-
gregation state of the peptide may influence the toxicity, a
more detailed examination of fibril formation is warranted.
We have set out to combine a variety of physicochemical
techniques to probe the self-assembly process of synthetic
peptides homologous to ,3-A/4. Here, we report our results
for ,3(1-28), which is a useful model peptide to study in
comparison to the longer peptides, for investigating the
role of the extracellular domain in self-assembly and fibril
formation.
CD results show that 13(1-28) does not adopt a regular
structure at 0.2 mg/ml in 0.02 M phosphate buffer. These
results are consistent with those reported by others for 13(1-
28) in phosphate buffer at pH 7.3 (Barrow and Zagorski,
1991) or in water at pH 2.8 (Barrow et al., 1992). In contrast,
Hilbich and coworkers reported that 13(1-27) contained 14%
13-sheet, 33% 1-turn, 7% a-helix, and 46% random coil un-
der similar conditions to ours (Hilbich et al., 1991a). Fraser
et al. (1991a) reported Fourier transform infrared experi-
ments which indicated that 13(1-28) at 5-20 mg/ml contained
70-80% 13-sheet at pH 4-7.The differences may be due to a
concentration dependence of formation of intermolecular
13-sheet structures.
Despite the lack of a detectable regular structure in solu-
tion, 13(1-28) self-assembles into small oligomers. Size-
exclusion HPLC analysis indicated that the peptide eluted at
molecular weights corresponding to tetrameric and mono-
meric species, with the tetramer dominating. Fibrils were not
detected eluting from the column, probably because they
were trapped by the guard column. Molecular weight de-
termination by size exclusion chromatography can be un-
certain due to variable elution times caused by alternate con-
formations (e.g., compact versus extended structures) or by
weak electrostatic interactions with the column. However,
SDS-PAGE experiments also showed that the major species
migrated with molecular weight close to that of a tetramer.
Others have also reported the presence of monomer and te-
tramer for 13(1-28), although the degree of tetramerization
was much less (Barrow et al., 1992).
Neither the total peak area nor the percent tetramer
changed significantly over a test period of 7-9 days. The
percent tetramer did not change substantially with concen-
tration, or in the presence or absence of NaCl in the sample
between the tetramer and monomer (i.e., over the time course
of the HPLC experiment), as evidenced by fairly sharp and
symmetric peaks. Thus, the tetramer appears to be a very
stable noncovalent oligomer of 13(1-28). It is surprising that
a stable oligomer is formed in the absence of a regular sec-
ondary structure. Since the CD spectra were taken in the
absence of NaCl (due to interference from its absorbance in
the UV) and the mobile phase in the HPLC experiments
contained NaCl (to reduce electrostatic interactions between
the peptide and the column), it is conceivable that the ad-
dition ofNaCl leads to rapid formation of secondary structure
with subsequent rapid assembly into tetramers. However, if
this were true, one might expect chromatograms for samples
prepared with and without NaCl to differ somewhat due to
the time delay for diffusion of NaCl from the mobile phase
into the sample, formation of secondary structure, and self-
assembly. This was not observed. Alternatively, the absence
of regular secondary structural features in the CD spectra
does not necessarily mean that the peptide is in a completely
random configuration (Woody, 1985).
The tetramer does not appear to bind ThT or Congo red.
This was shown in two ways: first, Congo red coinjected with
peptide eluted on HPLC as free dye. Second, peptide con-
centrations of 0.2 mg/ml contained significant amounts of
tetramer but did not bind Congo red or ThT. However, the
cross-,3 structure characteristic of amyloid fibrils is present
in these samples at concentrations of -0.3 mg/ml or greater.
We suggest that ThT and Congo red bind only to higher-order
aggregates, which we tentatively term protofibrils. It is con-
ceivable that these protofibrils correspond in some way to the
subunits reported by others in electron micrograph and x-ray
diffraction studies (Fraser et al., 1991b; Inouye et al., 1993).
Salt concentration is not a significant factor in determining
the minimum concentration required for the formation of
protofibrils.
Fibril formation kinetics of 1 mg/ml 13(1-28) solution in
0.01 M phosphate (sampleA) were studied in detail by light
scattering and electron microscopy. Analysis of CLS data is
not straightforward for this system. Polydispersity, intrapar-
ticle scattering interference, and intermolecular interactions
influence the scattering intensity. Conventional Zimm plots
are not appropriate because aggregation is a function of con-
centration. The accuracy of the values of (M)X and (R2)1/2
depend on the validity of the assumptions used to derive Eq.
2. The assumption that P(q)-' = 1 + q2(R)2z3 is valid for
rods to q2(Rg)z -4 (Geiduschek and Holtzer, 1958). Due to
the size of the aggregates formed in our work, this approxi-
mation is applicable only for scattering angles of -35° or
less. Nevertheless, in order to have a reasonable number of
data points to determine (R2)z, scattering intensities to -45°
were used in data fitting. A more difficult problem arises
because no correction for the second virial coefficientB was
made. Assuming only hard-core repulsive interactions, the
second virial coefficient can be calculated from
B TNAd(L ) (12)solution. There does not appear to be a rapid interconversion
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which is appropriate for long rods (Tracy and Pecora, 1992).
Using the values of (M/L), from Table 1 to calculate B from
Eq. 12, and applying this calculation to Eq. 1, leads to es-
timates that (M)w may be 1.1 to -4 times larger than (M)W,app
in some cases. This may be an overestimate of the correction
factor required, due to complications such as the broad poly-
dispersity and fibril flexibility. Attractive or repulsive solute-
solute interactions may further alter the numerical value of
B (Nicolai and Mandel, 1989a), but it is difficult to calculate
the magnitude of these effects. When (M)X is calculated di-
rectly from (M/L)w and L, results are reasonably consistent
with the values of (M)w,app reported in Table 1. Finally, it
should be noted that these peptide solutions are very poly-
disperse, and that the values reported reflect molecular prop-
erties averaged over all species in solution. For example, a
solution with (M)w = 106 could consist of 90 wt% tetramer
(M = 1.3 X 104) and 10% long fibrils (M = 107). (R2)z is
heavily weighted toward the larger particles and more likely
reflects primarily properties of the fibrils.
From CLS data at 24 h, the average fibril length was cal-
culated to be -900 nm. This is consistent with the fibril
lengths of 500-1000 nm seen on electron micrographs at 21
h. In contrast, multiangle analysis of QLS data and com-
parison to theoretical calculations of (F)/q2 for long rods
show that the measured diffusivities at 24 h are consistent
with fibril lengths of 2000-5000 nm. Moderate changes in
the assumed rod diameter (factor of 2-3) do not result in
substantially different values for (F)lq2.
Consideration of the interpretation of QLS data for long
thin rods is necessary to explain this apparent discrepancy.
The theoretical expressions (Eqs. 9 and 11) ignore the in-
fluence of polydispersity, rod flexibility, and fibril-fibril in-
teractions. The angular dependence seen in the data but not
in the theoretical calculations (Fig. 9) is most likely the result
of polydispersity. Rod flexibility would increase the diffu-
sivity above that for a stiff rod of the same contour length,
which does not explain the discrepancy in fibril length be-
tween QLS and EM data. Thermodynamic and hydrody-
namic interactions, which become increasingly important as
the concentration increases, influence the effective diffusiv-
ity measured in QLS experiments. Theoretical and experi-
mental work show that repulsive electrostatic interactions
increase the diffusive motion measured by QLS relative to
uncharged rods (Weyerich et al., 1990; Nicolai and Mandel,
1989b), which again does not explain the discrepancy be-
tween QLS and EM data.
The most likely explanations for the anomalously low dif-
fusivities are the formation of loose fibril aggregates and the
onset of caging, in which the rotational and sideways trans-
lational diffusion are reduced due to the effect of interactions
with neighboring rods. The effect of caging is estimated to
become measurable at values of NL3 > 35-50 (Keep and
Pecora, 1988), where N is the number density of rods. For
fibrils with lengths of - 1000 nm, and molecular weights of
-107, the corresponding concentration of fibrils at which
caging might be observed is -0.5-0.8 mg/ml, compared to
influence dynamic properties such as diffusion without al-
tering static properties such as radius of gyration.
At 48 h after sample preparation, the fibril length calcu-
lated from (R2) is -1500 nm, which is reasonably con-
sistent with the lengths estimated from the micrographs. At
longer time, however, there is no significant increase in
(R2)112, whereas Fig. 10 C shows extremely long fibrils of
indeterminant length. Two factors are probably contributing
to this apparent contradiction. First, the neglect of higher-
order terms in q in deriving Eq. 2 becomes less valid as the
particle size increases, leading to an underestimate of
(R2)1'2. Second, Eq. 3 is no longer appropriate as multifibril
aggregates emerge which do not have a thin rodlike shape.
For these aggregates, length increases much more rapidly
than (R2)'2.
From both (M)W,app and (Rh)z,appg a pattern of slow
growth, then rapid growth, was seen. The ratio (M)W(M)n
increased with time, suggesting an increase in the polydis-
persity of the mixture. (Rh)z,app increased dramatically after
-150 h, whereas (R2) '2 remained approximately constant.
This may be due in part to the breakdown in the assump-
tions of Eq. 2 as rod size increases, and the increasing im-
portance of caging on the diffusivity. The data may also
reflect a change in the structure of the aggregate, since the
ratio (Rh)Z/(R2)1'2 would increase as the aggregate changed
from an elongated to a more globular structure. This would
occur as fibrils aggregate into bundles.The linear density
(M/L)W and the corresponding diameter (d)w increased with
time, with a more rapid increase after 120 h. Note that (d)w
is that of an equivalent cylindrical rod with the same linear
density and does not necessarily correspond to the hydro-
dynamic diameter or to the diameter seen on the micro-
graphs. The fact that (d)w at early times is much less than the
10-nm diameter seen on the micrographs is a reflection of
both the contribution of small oligomers, such as tetramers,
to (d)w and possibly a flat or hollow fibril structure.
We interpret these data as showing that fibril formation
and elongation are the dominant processes occurring in the
first 150 h, followed by fibril-fibril interaction afterwards.
The rapid increase in size subsequent to 150 h is character-
istic of the formation of a network of fibrils. We hypothesize
that the early increase in (M/L)w (before --150 h) is due
primarily to the coalescence of "protofibrils" into fibrils and
that the later increase (-150-240 h) is due primarily to the
formation of bundles of fibrils.
Upon dilution to 0.5 mg/mi, (M)w,app, (M)n,appq (Rh)z,app,
(R2) 1/2and (M/L)w all decreased. (M/L)w dropped by a factor
of two, whereas (M)w,app decreased by a factor of six. At 388
h, (M)w,app is similar to that at 48 h, but (R2)1/2 is much
smaller and (M/L)w is much larger. This suggests that fibril
formation and/or fibril-fibril bundle formation are not en-
tirely reversible over the time scales investigated. Both dis-
entanglement of fibril bundles and fragmentation of indi-
vidual fibrils may occur upon dilution. However, fibril-fibril
interactions involve multiple contacts and are likely to be
a total peptide concentration of 1 mg/ml. Caging effects can
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more resistant to dissociation than individual fibrils. This
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concept would explain why the linear density of the aggre-
gate at equivalent molecular mass is greater after dilution. A
peptide solution made up fresh at 0.5 mg/ml concentration
scattered light too weakly to measure any aggregation even
after 7 days. This further supports the notion that aggregation
of 3(1-28) is under kinetic rather than thermodynamic con-
trol and that the sample history greatly influences the final
outcome.
NaCl plays a significant role in fibril growth rates and
fibril-fibril interactions. The importance of salt in self-
assembly of (3-sheet structures has been seen in other systems
(Hilbich et al., 1991b; Zhang et al., 1993). QLS data show
a remarkably greater rate of aggregation in the presence of
physiological salt concentrations (Fig. 11 versus Fig. 8). Salt
enhances fibril elongation, as evidenced by the generally
longer fibrils seen in the micrograph taken at early time.
(rF/q2 for samples C and D correspond to remarkably low
diffusivities after 4-8 h. These diffusivities cannot be at-
tributed to isolated fibrils. Instead, both caging and interfi-
brillary aggregation are likely explanations for these low dif-
fusivities. We hypothesize that at high ionic strength fibril-
fibril interactions occur very early on and are the major
reason for the much greater rate of aggregation seen in the
samples containing NaCl.
Electron micrographs taken after several weeks show two
different patterns of fibril aggregates, depending on salt con-
centration. At the lower ionic strength, fibrils formed a mesh
or network of entangled fibrils, with very little correlation of
direction (Fig. 10 C). At the higher ionic strength, fibrils
tended to align and form bundles (Fig. 10 E). Similar to our
findings, Fraser et al. (1991a, 1992) reported that lateral ag-
gregation of ((11-28) increased with increasing ionic
strength. Nonrandom orientation of fibrils may occur simply
due to hard core interactions at high concentrations. Keep
and Pecora (1988) showed that a nonrandom orientation of
rods must occur at NL2d > 2.26, and may occur at lower
values. If fibril length and/or fibril density is greater at the
higher ionic strength, then hard-core interactions alone could
account for the difference in fibril orientation. It should be
noted that the maximum concentration for random orienta-
tion refers to the concentration of fibrils, but HPLC and gel
electrophoresis data show that much of the peptide is not in
fibrillar form. Thus, we suspect that the orientation of the
fibrils at the high ionic strength is not due solely to packing
considerations, but that attractive interfibrillary interactions
play a role. A combination of electrostatic and hydrophobic
interactions may account for these results. Repulsive elec-
trostatic interactions at low ionic strength may cause the
fibrils to maintain maximum interfibrillary distances and
lead to a mesh-like network. At the higher ionic strength,
electrostatic forces are more effectively screened and align-
ment could occur due to hydrophobic interactions which fa-
vor fibril-fibril interactions over fibril-solvent interactions.
Our experiments show, not surprisingly, that fibril for-
mation is a strong function of concentration. At physiological
pH and ionic strength, we saw no fibril formation at 0.2
mation at concentrations of 0.5 mg/ml or greater, with the
rate faster at the higher concentration. In this case, fibril
formation occurred only at concentrations at which ThT and
Congo red binding were detected. However, the opposite is
not true. At the lower ionic strength, no fibril formation was
detected by light scattering at 0.5 mg/ml concentration, even
after 7 days incubation, despite the presence of ThT- and
Congo red-binding species. This suggests that the presence
of the hypothesized protofibrils is not in itself sufficient for
fibril formation.
It is interesting to note that there are no short fibrils seen
on the micrographs. One possible explanation is that fibril
formation is autocatalytic, in that once a fibril starts to form,
its elongation is very rapid. Alternatively, it could be due to
difficulties in imaging shorter fibrils or protofibrils or wash-
ing off shorter fibrils from the grid. We suspect the latter is
true for the following reason. The fibril density seen on the
micrographs clearly increased dramatically with time, yet the
peak areas (and presumably the concentration) of monomer
and tetramer measured by HPLC did not change with time.
One explanation that would be consistent with these data is
that protofibrils are formed rapidly if the concentration is
high enough, and these protofibrils, but not the tetramers or
monomers, participate in the relatively slow process of fibril
formation and elongation.
The appearance of a damped oscillatory autocorrelation
function, which was seen at 240 h for sample A and 8 h for
sample D, may be indicative of the strong correlations be-
tween fibrils that exist at this point. Oscillatory autocorre-
lation functions in other systems have been attributed to the
onset of gelation and bulk motion of solvent and solute be-
tween two phases (Shukla et al., 1992). We did not see any
macroscopic evidence of gelation or of phase separation in
our systems; however, microgels may have formed. For the
sample made by dilution from the TFA stock solution, mea-
surements of the autocorrelation function (ACF) were con-
tinued after the initial appearance of the damped oscillatory
ACF. The ACF signal weakened with time, whereas the total
intensity did not change much. This may indicate that fibrils
eventually form stiff entangled microgels, which contribute
a static component to the scattering intensity.
It is clear from our data that a careful distinction must be
made between solubility, fibril formation and elongation, in-
terfibrillary aggregation, and phase separation when describ-
ing the physical properties of (3(1-28). For example, despite
clear evidence of amyloid fibril formation there was never
any visible indication of loss of solubility. As another ex-
ample, our data for sample A suggest that fibril formation is
rapid and immediate, whereas there is a lag time for inter-
fibrillary aggregation.
Sample preparation method influences fibril formation re-
markably. Sample B was prepared by dissolving peptide first
into the low ionic strength buffer used for sample A, then
adjusting the salt concentration to that of sample D. Fibril
growth rates for sample B were similar to sample A over the
first 24 h. At later times, however, the aggregation behavior
mg/ml even after 9 days, but rapid and immediate fibril for-
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of sample B became more like sample D. For the sample
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prepared from 0.1% TFA stock solution and diluted into
PBSA, the size of the aggregates was similar to that for
samples prepared by direct dissolution of lyophilized peptide
into the same buffer. However, the number density was much
lower, as evidenced by both the lower intensity of scattered
light and the reduced number of fibrils on micrographs. Sur-
prisingly, if the solution was prepared by diluting the TFA
stock solution first into a low salt, then into a high salt buffer,
no fibrils were detectable.
Our work clearly indicates that the aggregation mecha-
nism of ,3(1-28) is very complex, and support the notion that
the aggregation state is kinetically rather than thermody-
namically determined. Sample preparation method, sample
history, initial concentration, pH, ionic strength, time, and
dilution all strongly affect the resulting aggregate concen-
tration, size, and morphology. If the state of aggregation of
the peptide is important in determining its toxicity, as has
been suggested, than these factors must be carefully con-
trolled for a realistic assessment of the in vivo and in vitro
biological activity of ,B-amyloid peptide.
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